141 related articles for article (PubMed ID: 23970396)
1. Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer.
Akagi Y; Shirouzu K; Kinugasa T
J Surg Oncol; 2013 Nov; 108(6):358-63. PubMed ID: 23970396
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
3. Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.
Karoui M; Roudot-Thoraval F; Mesli F; Mitry E; Aparicio T; Des Guetz G; Louvet C; Landi B; Tiret E; Sobhani I
Dis Colon Rectum; 2011 Aug; 54(8):930-8. PubMed ID: 21730780
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer.
Al Sahaf O; Myers E; Jawad M; Browne TJ; Winter DC; Redmond HP
Dis Colon Rectum; 2011 Aug; 54(8):982-8. PubMed ID: 21730787
[TBL] [Abstract][Full Text] [Related]
5. Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy.
Malik YG; Lyckander LG; Lindstrøm JC; Vinge-Holmquist O; Sheikh AE; Schultz JK; Ignjatovic D
J Cancer Res Clin Oncol; 2021 Jan; 147(1):61-71. PubMed ID: 32924067
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
8. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
[TBL] [Abstract][Full Text] [Related]
13. Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
Neuzillet Y; Lebret T; Molinie V; Yonneau L; Herve JM; Theodore C; Botto H
BJU Int; 2012 Dec; 110(11):1736-41. PubMed ID: 22998125
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
Liang YH; Shao YY; Chen HM; Cheng AL; Lai MS; Yeh KH
Anticancer Res; 2017 Dec; 37(12):7095-7104. PubMed ID: 29187501
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
19. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
20. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
